TXG logo

10x Genomics, Inc. (TXG) Cash From Operations

Annual CFO:

$6.66M+$21.86M(+143.85%)
December 31, 2024

Summary

  • As of today, TXG annual cash from operations is $6.66 million, with the most recent change of +$21.86 million (+143.85%) on December 31, 2024.
  • During the last 3 years, TXG annual cash from operations has risen by +$28.04 million (+131.18%).
  • TXG annual cash from operations is now -80.75% below its all-time high of $34.63 million, reached on December 31, 2019.

Performance

TXG Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Quarterly CFO:

$43.21M+$25.51M(+144.04%)
September 30, 2025

Summary

  • As of today, TXG quarterly cash from operations is $43.21 million, with the most recent change of +$25.51 million (+144.04%) on September 30, 2025.
  • Over the past year, TXG quarterly cash from operations has increased by +$21.57 million (+99.69%).
  • TXG quarterly cash from operations is now at all-time high.

Performance

TXG Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM CFO:

$88.53M+$21.57M(+32.22%)
September 30, 2025

Summary

  • As of today, TXG TTM cash from operations is $88.53 million, with the most recent change of +$21.57 million (+32.22%) on September 30, 2025.
  • Over the past year, TXG TTM cash from operations has increased by +$49.35 million (+126.00%).
  • TXG TTM cash from operations is now at all-time high.

Performance

TXG TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TXG Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+143.8%+99.7%+126.0%
3Y3 Years+131.2%+551.8%+313.2%
5Y5 Years-80.8%+177.7%+209.3%

TXG Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+119.8%at high+270.8%at high+313.2%
5Y5-Year-80.8%+103.1%at high+133.2%at high+140.3%
All-TimeAll-Time-80.8%+103.1%at high+133.2%at high+140.3%

TXG Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$43.21M(+144.0%)
$88.53M(+32.2%)
Jun 2025
-
$17.71M(-48.4%)
$66.95M(+18.0%)
Mar 2025
-
$34.35M(+609.1%)
$56.74M(+751.4%)
Dec 2024
$6.66M(+143.9%)
-$6.75M(-131.2%)
$6.66M(-83.0%)
Sep 2024
-
$21.64M(+188.7%)
$39.17M(+603.8%)
Jun 2024
-
$7.50M(+147.7%)
-$7.78M(+71.0%)
Mar 2024
-
-$15.72M(-161.0%)
-$26.80M(-76.3%)
Dec 2023
-$15.20M(+54.8%)
$25.76M(+201.8%)
-$15.20M(+44.2%)
Sep 2023
-
-$25.30M(-119.5%)
-$27.23M(-137.0%)
Jun 2023
-
-$11.53M(-179.4%)
-$11.49M(+32.1%)
Mar 2023
-
-$4.13M(-130.1%)
-$16.93M(+49.6%)
Dec 2022
-$33.61M
$13.72M(+243.5%)
-$33.61M(+19.1%)
Sep 2022
-
-$9.56M(+43.6%)
-$41.52M(+28.6%)
Jun 2022
-
-$16.96M(+18.5%)
-$58.18M(-52.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$20.80M(-458.3%)
-$38.09M(-78.2%)
Dec 2021
-$21.37M(+90.2%)
$5.80M(+122.1%)
-$21.37M(+86.4%)
Sep 2021
-
-$26.22M(-940.3%)
-$157.35M(+15.7%)
Jun 2021
-
$3.12M(+176.4%)
-$186.77M(+14.9%)
Mar 2021
-
-$4.08M(+96.9%)
-$219.40M(-0.7%)
Dec 2020
-$217.90M(-729.3%)
-$130.18M(-134.0%)
-$217.90M(-168.9%)
Sep 2020
-
-$55.63M(-88.5%)
-$81.02M(-645.5%)
Jun 2020
-
-$29.52M(-1045.9%)
-$10.87M(-147.8%)
Mar 2020
-
-$2.58M(-138.4%)
$22.73M(-34.3%)
Dec 2019
$34.63M(+145.3%)
$6.70M(-53.9%)
$34.63M(+24.0%)
Sep 2019
-
$14.53M(+255.8%)
$27.93M(+108.4%)
Jun 2019
-
$4.08M(-56.2%)
$13.40M(+43.8%)
Mar 2019
-
$9.32M
$9.32M
Dec 2018
-$76.41M(-614.2%)
-
-
Dec 2017
-$10.70M
-
-

FAQ

  • What is 10x Genomics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual cash from operations year-on-year change?
  • What is 10x Genomics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly cash from operations year-on-year change?
  • What is 10x Genomics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM cash from operations year-on-year change?

What is 10x Genomics, Inc. annual cash from operations?

The current annual cash from operations of TXG is $6.66M

What is the all-time high annual cash from operations for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual cash from operations is $34.63M

What is 10x Genomics, Inc. annual cash from operations year-on-year change?

Over the past year, TXG annual cash from operations has changed by +$21.86M (+143.85%)

What is 10x Genomics, Inc. quarterly cash from operations?

The current quarterly cash from operations of TXG is $43.21M

What is the all-time high quarterly cash from operations for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly cash from operations is $43.21M

What is 10x Genomics, Inc. quarterly cash from operations year-on-year change?

Over the past year, TXG quarterly cash from operations has changed by +$21.57M (+99.69%)

What is 10x Genomics, Inc. TTM cash from operations?

The current TTM cash from operations of TXG is $88.53M

What is the all-time high TTM cash from operations for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM cash from operations is $88.53M

What is 10x Genomics, Inc. TTM cash from operations year-on-year change?

Over the past year, TXG TTM cash from operations has changed by +$49.35M (+126.00%)
On this page